FutureChem Co.,Ltd (220100.KQ)

KRW 20750.0

(-6.74%)

Market Cap (In KRW)

458.51 Billion

Revenue (In KRW)

13.96 Billion

Net Income (In KRW)

-6.7 Billion

Avg. Volume

415.66 Thousand

Currency
KRW
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7960.0-31250.0
PE
-
EPS
-
Beta Value
1.256
ISIN
KR7220100002
CUSIP
-
CIK
-
Shares
22096973.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Dae-Yoon Chi
Employee Count
-
Website
https://www.futurechem.co.kr
Ipo Date
2016-12-01
Details
FutureChem Co.,Ltd produces and sells radiopharmaceuticals in Korea. The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson's disease; Alzavue, a diagnostic medicine for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer. Its products in pipeline include 18F-FC303, a diagnostic PET radiopharmaceuticals for the treatment of prostate cancer; 177Lu-FC705 for the treatment of prostate cancer; 18F-FMT for the treatment of brain tumor; 18F-FC505, for the treatment of atherosclerotic plaque; and 18F-FC211, for the treatment of Alzheimer's disease. FutureChem Co.,Ltd was founded in 1999 and is headquartered in Seoul, South Korea.

More Stocks